Curesign Ltd. ^{For Profit}

CureSign is a medical device company that is developing a product to revolutionize the way oncologists treat cancer patients. Their solution involves integrating advanced sensors with signal processing and big data tools to create a patient-specific treatment plan for each cancer patient. The technology has been successfully demonstrated in preclinical studies, and they are currently working on a commercial product that can be used in preclinical trials in the field of oncology. For more information, contact them at [email protected]